F Carneiro, A Vinceneux, M Larroquette, M Rony, L Carril, B Laguerre, I Blazevic, P Bartelemy, D Teyssonneau, M Goujon, C Linassier, A Thiery-Vuillemin, G Roubaud, L Mourey, L Albiges, G Gravis, M Gross-Goupil, M Cancel
BACKGROUND: Among patients with renal cell carcinoma (RCC), bone and visceral metastases have a poor prognosis, while endocrine gland metastases have a more favorable prognosis. Gastrointestinal metastases (GIMs) are rare, and their prognosis is still poorly understood. OBJECTIVES: To report clinical presentations, patient characteristics, therapeutic strategies, and prognosis of GIMs from RCC. METHODS: We retrospectively collected data from RCC patients presenting GIMs, in 10 French GETUG centers, between 2000 and 2021...
March 2024: European Journal of Cancer